The role of apoptosis and the effect of epidermal growth factor on proapoptotic BNIP 3 in an experimental rat priapism model

The role of apoptosis and the effect of epidermal growth factor on proapoptotic BNIP 3 in an experimental rat priapism model

Background/aim: This study aimed to investigate the effects of apoptosis-inducing Bcl-2/adenovirus E1B 19 kDa-interacting protein 3(BNIP 3) and antiapoptotic epidermal growth factor (EGF) on the pathophysiology of experimental low-flow priapism.Materials and methods: Twenty-four adult Sprague-Dawley rats were divided into four equal groups. Group I was the control group.Ischemic priapism was induced for 4 h in Group II rats. In Group III, intraperitoneal EGF at 10 µg/kg was given for 7 days beforeinduction of ischemic priapism for 4 h. In Group IV, intraperitoneal EGF at 20 µg/kg was given for 7 days before induction of ischemicpriapism for 4 h. The western blot method was used to determine BNIP 3 expression levels and the TUNEL method was used todetermine the apoptotic cells in the cavernosal tissue samples.Results: Although BNIP 3 expression levels were significantly higher in all three study groups compared to the controls, BNIP 3 wassignificantly higher in EGF-administered groups when compared to Group II (P < 0.05). The TUNEL score of group II was significantlyhigher than those of the other groups.Conclusion: Decreased apoptosis in cavernosal tissues obtained by antagonizing the apoptotic effect of BNIP 3 with EGF may facilitatethe development of new conservative treatment methods via those pathways.

___

  • Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A. American Urological Association guideline on the management of priapism. J Urol 2003; 170: 1318-1324.
  • Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med 2010; 7: 476-500.
  • Bennett N, Mulhall J. Sickle cell disease status and outcomes of African-American men presenting with priapism. J Sex Med 2008; 5: 1244-1250.
  • Chen G, Ray R, Dubik D, Shi L, Chizeau J, Bleackley RC, Saxena S, Gietz RD, Greenberg AH. The E1B 19K/Bcl-2- binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J Exp Med 1997; 186: 1975-1983.
  • Cizeau J, Ray R, Chen G, Gietz RD, Greenberg AH. The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanism. Oncogene 2000; 19: 5453-5463.
  • Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S, Hakem R, Greenberg AH. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 2000; 20: 5454-5468.
  • Zhou W, Yang J, Zhang DI, Li F, Li G, Gu Y, Luo M. Role of Bcl2/adenovirus E1B 19 kDa interacting protein 3 in myocardial cells in diabetes. Exp Ther Med 2015; 10: 67-73.
  • Huang Z, Ye B, Dai Z, Wu X, Lu Z, Shan P, Huang W. Curcumin inhibits autophagy and apoptosis in hypoxia/reoxygenationinduced myocytes. Mol Med Rep 2015; 11: 4678-4684.
  • Ye F, Wang H, Zhang L, Zou Y, Han H, Huang J. Baicalein induces human osteosarcoma cell line MG-63 apoptosis via ROS-induced BNIP3 expression Tumour Biol 2015; 36: 4731- 4740.
  • Lu P, Kamboj A, Gibson SB, Anderson CM. Poly(ADP-ribose) polymerase-1 causes mitochondrial damage and neuron death mediated by Bnip3. J Neurosci 2014; 34: 15975-15987.
  • Kiess W, Gallaher B. Hormonal control of programmed cell death/apoptosis. Eur J Endocrinol 1998; 138: 482-91.
  • Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331.
  • Rubin R, Baserga R. Biology of disease: IGF-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab Invest 1995; 73: 311-331.
  • Takeuchi K, Motoda Y, Ito F. Role of transcription factor activator protein 1 (AP1) in epidermal growth factor-mediated protection against apoptosis induced by a DNA-damaging agent. FEBS J 2006; 273: 3743-3755.
  • Kothari S, Cizeau J, McMillan-Ward E, Israels SJ, Bailes M, Ens K, Kirshenbaum LA, Gibson SB. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 2003; 22: 4734-4744.
  • Sanli O, Armagan A, Kandirali E, Ozerman B, Ahmedov I, Solakoglu S, Nurten A, Tunç M, Uysal V, Kadioglu A. TGF-b1 neutralizing antibodies decrease the fibrotic effects of ischemic priapism. Int J Impot Res 2004; 16: 492-497.
  • Karakeci A, Firdolas F, Ozan T, Unus I, Ogras MS, Orhan I. Second pathways in the pathophysiology of ischemic priapism and treatment alternatives. Urology 2013; 82: 625-629.
  • Kucukdurmaz F, Kucukgergin C, Akman T, Salabas E, Armagan A, Seckin S, Kadioglu A. Duration of priapism is associated with increased corporal oxidative stress and antioxidant enzymes in a rat model. Andrologia 2016; 48: 374-379.
  • Broderick GA, Gordon D, Hypolite J, Levin RM. Anoxia and corporal smooth muscle dysfunction: a model for ischemic priapism. J Urol 1994; 151: 259-262.
  • Bruick RK. Expression of the gene encoding the proapoptotic BNip3 protein is induced by hypoxia. P Natl Acad Sci USA 2000; 97: 9082-9087.
  • Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. P Natl Acad Sci USA 2002; 99: 12825-12830.
  • Ishihara M, Urushido M, Hamada K, Matsumoto T, Shimamura Y, Ogata K, Inoue K, Taniguchi Y, Horino T, Fujieda M et al. Sestrin-2 and BNIP3 regulate autophagy and mitophagy in renal tubular in acute kidney injury. Am J Physiol Renal Physiol 2013; 305: 495-509.
  • Schmidt-Kastner R, Aguirre-Chen C, Kietzmann T, Saul I, Busto R, Ginsberg MD. Nuclear localization of the hypoxiaregulated pro-apoptotic protein BNIP3 after global brain ischemia in the rat hippocampus. Brain Res 2004; 1001: 133- 142.
  • Grinman DY, Romorini L, Presman DM, Rocha-Viegas L, Coso OA, Davio C, Pecci A. Role of 3’-5’-cyclic adenosine monophosphate on the epidermal growth factor dependent survival in mammary epithelial cells. Mol Cell Endocrinol 2016; 419: 259-267.
  • Fabregat I, Sánchez A, Alvarez AM, Nakamura T, Benito M. Epidermal growth factor, but not hepatocyte growth factor, suppresses the apoptosis induced by transforming growth factor – beta in fetal hepatocytes in primary culture. FEBS Lett 1996; 384: 14-18.
  • Ilio KY, Sensibar JA, Lee C. Effect of TGF-β1, TGF-α and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture. J Androl 1995; 16: 482-490.
  • Gibson EM, Henson ES, Haney N, Villanueva J, Gibson SB. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligandinduced apoptosis by inhibiting cytochrome c release. Cancer Res 2002; 62: 488-496.
  • Kilinc F, Kayaselcuk F, Aygun C, Guvel S, Egilmez T, Ozkardes H. Experimental varicocele induces hypoxia inducible factor-1α, vascular endothelial growth factor expression and angiogenesis in the rat testis. J Urol 2004; 172: 1188-1191.